Sound Income Strategies’s Neuropace NPCE Stock Holding History

Sound Income Strategies’s Portfolio NPCE Stock Details NPCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-21	Closed	-$295	–	1735
2026 Q1	$295	Hold	21	–	–	﹤0.01%	2449
2025 Q4	$356	Hold	21	–	–	﹤0.01%	2403
2025 Q3	$227	Hold	21	–	–	﹤0.01%	1594
2025 Q2	$234	Hold	21	–	–	﹤0.01%	1520
2025 Q1	$258	Buy	+21	New	+$263	﹤0.01%	1462

Other funds holding NPCE

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PWM

Palumbo Wealth Management Great Neck, New York $478M AUM 50.95% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HWM

HighMark Wealth Management St. Paul, Minnesota $299M AUM 53.01% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Sound Income Strategies's NPCE Position: Q2 2026 in Review

Sound Income Strategies sold out of Neuropace (NPCE) in Q2 2026, closing a stake of 21 shares — an estimated $295 sold.

Sound Income Strategies first reported a position in NPCE in Q1 2025 and held it in 5 quarters. The position peaked at $356 in Q4 2025. 46 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

Sound Income Strategies reported no remaining Neuropace position as of Q2 2026 after selling out during the quarter.
Sound Income Strategies sold 21 Neuropace shares in Q2 2026, an estimated $295.
Sound Income Strategies first reported a position in Neuropace in Q1 2025 and held it in 5 quarters.
Sound Income Strategies's Neuropace position peaked at $356 in Q4 2025.
46 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.